CompletedPhase 3NCT00195793

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

Studying Disorder of lipid metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Abbott
Principal Investigator
Global Medical Information
Abbott
Intervention
fenofibrate(drug)
Enrollment
174 target
Eligibility
18 years · All sexes
Timeline
2004

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00195793 on ClinicalTrials.gov

Other trials for Disorder of lipid metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of lipid metabolism

← Back to all trials